Source: MarketScreener

Leap Therapeutics: Leap Therapeutics : to Present at 39th Annual J.P. Morgan Healthcare Conference

(marketscreener.com) CAMBRIDGE, Mass., Jan. 4, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. , a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at the 39th Annual J.P. Morgan Healthcare Conference. The conference...https://www.marketscreener.com/quote/stock/LEAP-THERAPEUTICS-INC-33375941/news/Leap-Therapeutics-to-Present-at-39th-Annual-J-P-Morgan-Healthcare-Conference-32115329/?utm_medium=RSS&utm_content=20210104

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Chris Mirabelli's photo - CEO of Leap Therapeutics

CEO

Chris Mirabelli

CEO Approval Rating

73/100

Leap Therapeutics researches, develops and commercializes monoclonal antibodies that enable immune system to identify and attack cancer cells. Read more